Pharmacies as potential providers of harm reduction services: A preliminary online survey
Drug Science Policy and Law January 1, 2018 Edward James, Thomas L Robertshaw, Andrew D. Westwell et al. 4 citations
A survey of 105 UK nationals found that participants viewed pharmacists, supported by general practitioners and mental health workers, as the most suitable vendors for cannabis, MDMA, and psilocybin, compared to regulated shops or the black market. Support for selling cannabis in pharmacies for therapeutic and harm reduction purposes averaged 7.0 out of 10. Participants with a university education were more in favor of pharmacy sales for alcohol (5.6), tobacco (6.7), cannabis (7.6), MDMA (6.5), and psilocybin (6.5) than those without a university qualification (alcohol 5.0, tobacco 4.8, cannabis 6.3, MDMA 5.0, psilocybin 5.1). The findings suggest that university-educated participants support treating recreational drug use as a health issue.